Cantor Fitzgerald Reiterates “Overweight” Rating for Molina Healthcare (NYSE:MOH)

Cantor Fitzgerald reiterated their overweight rating on shares of Molina Healthcare (NYSE:MOH) in a research report released on Thursday morning, Benzinga reports. The firm currently has a $406.00 price objective on the stock.

Several other brokerages have also issued reports on MOH. Stephens reissued an “equal weight” rating and set a $320.00 price objective on shares of Molina Healthcare in a research report on Thursday, July 25th. TD Cowen dropped their price objective on Molina Healthcare from $412.00 to $351.00 and set a “buy” rating on the stock in a report on Wednesday, July 24th. Truist Financial reduced their target price on shares of Molina Healthcare from $440.00 to $400.00 and set a “buy” rating for the company in a research note on Monday, July 15th. Wells Fargo & Company raised their price target on shares of Molina Healthcare from $315.00 to $360.00 and gave the company an “equal weight” rating in a report on Monday, August 5th. Finally, Jefferies Financial Group decreased their price objective on shares of Molina Healthcare from $354.00 to $297.00 and set a “hold” rating for the company in a report on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $371.83.

Molina Healthcare Price Performance

Shares of MOH traded up $15.84 during mid-day trading on Thursday, hitting $339.43. The company’s stock had a trading volume of 601,963 shares, compared to its average volume of 521,024. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57. Molina Healthcare has a fifty-two week low of $272.69 and a fifty-two week high of $423.92. The firm has a 50-day moving average price of $335.72 and a 200 day moving average price of $330.46. The stock has a market capitalization of $19.89 billion, a price-to-earnings ratio of 18.65, a PEG ratio of 0.99 and a beta of 0.58.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, October 23rd. The company reported $6.01 EPS for the quarter, topping the consensus estimate of $5.96 by $0.05. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The business had revenue of $10.34 billion during the quarter, compared to analysts’ expectations of $9.92 billion. During the same period last year, the company posted $5.05 earnings per share. The firm’s quarterly revenue was up 21.0% compared to the same quarter last year. On average, research analysts predict that Molina Healthcare will post 23.5 EPS for the current fiscal year.

Insider Activity

In related news, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the transaction, the chief accounting officer now owns 9,473 shares of the company’s stock, valued at $3,282,583.96. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CAO Maurice Hebert sold 393 shares of the stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the sale, the chief accounting officer now owns 9,473 shares of the company’s stock, valued at $3,282,583.96. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the sale, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by company insiders.

Institutional Trading of Molina Healthcare

A number of institutional investors have recently made changes to their positions in MOH. Capital International Investors boosted its stake in shares of Molina Healthcare by 0.9% during the 1st quarter. Capital International Investors now owns 1,665,801 shares of the company’s stock worth $684,361,000 after buying an additional 15,264 shares during the last quarter. Renaissance Technologies LLC raised its position in Molina Healthcare by 13.3% during the second quarter. Renaissance Technologies LLC now owns 949,691 shares of the company’s stock worth $282,343,000 after acquiring an additional 111,154 shares in the last quarter. Boston Partners lifted its stake in Molina Healthcare by 14.8% in the first quarter. Boston Partners now owns 798,950 shares of the company’s stock valued at $328,101,000 after acquiring an additional 103,245 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Molina Healthcare by 22.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 470,932 shares of the company’s stock valued at $140,026,000 after acquiring an additional 84,929 shares during the period. Finally, AQR Capital Management LLC increased its stake in shares of Molina Healthcare by 36.2% during the 2nd quarter. AQR Capital Management LLC now owns 463,537 shares of the company’s stock worth $137,810,000 after purchasing an additional 123,121 shares during the last quarter. Institutional investors own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.